French
English
Arabic
Arabic No products in the cart.
Orchidia acquired a market share of 36.8% of the IMS dry eye market, according to the company's data to lead the market with sales of 50 million pounds in the first half of 2017, due to the great success achieved by Solofresh which was launched at the beginning of the year and achieved sales of 36 million pounds in the first half with market share 26.4%
Orchidia seeks full control of this market and its market share will reach 50% over the next two years by offering a group of single dose unit that are first introduced in the Egyptian market